1. Home
  2. SWTX vs DBRG Comparison

SWTX vs DBRG Comparison

Compare SWTX & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • DBRG
  • Stock Information
  • Founded
  • SWTX 2017
  • DBRG 1991
  • Country
  • SWTX United States
  • DBRG United States
  • Employees
  • SWTX N/A
  • DBRG N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • DBRG Real Estate Investment Trusts
  • Sector
  • SWTX Health Care
  • DBRG Real Estate
  • Exchange
  • SWTX Nasdaq
  • DBRG Nasdaq
  • Market Cap
  • SWTX 2.8B
  • DBRG 2.3B
  • IPO Year
  • SWTX 2019
  • DBRG 2009
  • Fundamental
  • Price
  • SWTX $34.63
  • DBRG $11.27
  • Analyst Decision
  • SWTX Strong Buy
  • DBRG Strong Buy
  • Analyst Count
  • SWTX 6
  • DBRG 8
  • Target Price
  • SWTX $68.83
  • DBRG $17.38
  • AVG Volume (30 Days)
  • SWTX 1.5M
  • DBRG 2.3M
  • Earning Date
  • SWTX 02-25-2025
  • DBRG 02-20-2025
  • Dividend Yield
  • SWTX N/A
  • DBRG 0.35%
  • EPS Growth
  • SWTX N/A
  • DBRG 1689.35
  • EPS
  • SWTX N/A
  • DBRG 0.76
  • Revenue
  • SWTX $135,487,000.00
  • DBRG $876,649,000.00
  • Revenue This Year
  • SWTX $3,413.86
  • DBRG N/A
  • Revenue Next Year
  • SWTX $88.52
  • DBRG N/A
  • P/E Ratio
  • SWTX N/A
  • DBRG $10.99
  • Revenue Growth
  • SWTX N/A
  • DBRG 680.46
  • 52 Week Low
  • SWTX $28.21
  • DBRG $10.25
  • 52 Week High
  • SWTX $53.92
  • DBRG $20.99
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 43.67
  • DBRG 47.87
  • Support Level
  • SWTX $31.96
  • DBRG $10.60
  • Resistance Level
  • SWTX $44.01
  • DBRG $11.68
  • Average True Range (ATR)
  • SWTX 3.20
  • DBRG 0.44
  • MACD
  • SWTX -0.47
  • DBRG 0.09
  • Stochastic Oscillator
  • SWTX 19.53
  • DBRG 71.33

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centers, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

Share on Social Networks: